Profiling the subjective effects of Δ 9 ‐tetrahydrocannabinol using visual analogue scales

Abstract The subjective effects of cannabis and its main psychoactive component Δ 9 ‐tetrahydrocannabinol (THC) have played an important part in determining the therapeutic potential of cannabinoid agonists and antagonists. The effects mainly consist of feeling high, changes in perception, feelings...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of methods in psychiatric research Vol. 23; no. 2; pp. 245 - 256
Main Authors Kleinloog, Daniël, Roozen, Frits, De Winter, Willem, Freijer, Jan, Van Gerven, Joop
Format Journal Article
LanguageEnglish
Published 01.06.2014
Online AccessGet full text

Cover

Loading…
Abstract Abstract The subjective effects of cannabis and its main psychoactive component Δ 9 ‐tetrahydrocannabinol (THC) have played an important part in determining the therapeutic potential of cannabinoid agonists and antagonists. The effects mainly consist of feeling high, changes in perception, feelings of relaxation and occasionally dysphoric reactions. These effects are captured by two of the most frequently used visual analogue scales (VASs) in clinical (pharmacologic) research to measure subjective effects: VAS Bond and Lader (alertness, calmness and mood) and VAS Bowdle (psychedelic effects). In this analysis, the effects of THC on these VASs were compared within a total of 217 subjects who participated in 10 different studies. Not surprisingly, the item feeling high was found to be the best predictor for the effect of THC. Three separate clusters that describe the spectrum of subjective effects of THC were identified using different statistical methods, consisting of VAS “time”, “thoughts” and “high” (“perception”), VAS “drowsy”, “muzzy”, “mentally slow” and “dreamy” (“relaxation”) and VAS “voices”, “meaning” and “suspicious” (“dysphoria”). These results provide experimental evidence that THC can evoke different classes of effects. These distinct subjective clusters could represent effects on various systems in the brain, which can be used to further differentiate the involvement of endocannabinoid systems in health and disease. Copyright © 2014 John Wiley & Sons, Ltd.
AbstractList Abstract The subjective effects of cannabis and its main psychoactive component Δ 9 ‐tetrahydrocannabinol (THC) have played an important part in determining the therapeutic potential of cannabinoid agonists and antagonists. The effects mainly consist of feeling high, changes in perception, feelings of relaxation and occasionally dysphoric reactions. These effects are captured by two of the most frequently used visual analogue scales (VASs) in clinical (pharmacologic) research to measure subjective effects: VAS Bond and Lader (alertness, calmness and mood) and VAS Bowdle (psychedelic effects). In this analysis, the effects of THC on these VASs were compared within a total of 217 subjects who participated in 10 different studies. Not surprisingly, the item feeling high was found to be the best predictor for the effect of THC. Three separate clusters that describe the spectrum of subjective effects of THC were identified using different statistical methods, consisting of VAS “time”, “thoughts” and “high” (“perception”), VAS “drowsy”, “muzzy”, “mentally slow” and “dreamy” (“relaxation”) and VAS “voices”, “meaning” and “suspicious” (“dysphoria”). These results provide experimental evidence that THC can evoke different classes of effects. These distinct subjective clusters could represent effects on various systems in the brain, which can be used to further differentiate the involvement of endocannabinoid systems in health and disease. Copyright © 2014 John Wiley & Sons, Ltd.
Author Freijer, Jan
De Winter, Willem
Roozen, Frits
Van Gerven, Joop
Kleinloog, Daniël
Author_xml – sequence: 1
  givenname: Daniël
  surname: Kleinloog
  fullname: Kleinloog, Daniël
  organization: Centre for Human Drug Research Leiden The Netherlands
– sequence: 2
  givenname: Frits
  surname: Roozen
  fullname: Roozen, Frits
  organization: Centre for Human Drug Research Leiden The Netherlands
– sequence: 3
  givenname: Willem
  surname: De Winter
  fullname: De Winter, Willem
  organization: Centre for Human Drug Research Leiden The Netherlands
– sequence: 4
  givenname: Jan
  surname: Freijer
  fullname: Freijer, Jan
  organization: Centre for Human Drug Research Leiden The Netherlands
– sequence: 5
  givenname: Joop
  surname: Van Gerven
  fullname: Van Gerven, Joop
  organization: Centre for Human Drug Research Leiden The Netherlands
BookMark eNotkMtKAzEYhYMo2FbBR8jSzdTck1lK8QYFXXQrwz-ZpJ0yTUoyU-jOR3Dhc_kQPolTdHXO5nwcvik6DzE4hG4omVNC2N1un-ZUMHGGJlRKXRAl9fnYiSgLU3J6iaY5bwmhhjE1Qe9vKfq2a8Ma9xuH81Bvne3bg8PO-7FlHD3-_sIl_vn47F2fYHNsUrQQAtRtiB0e8ml8aPMAHYYAXVwPI8hC5_IVuvDQZXf9nzO0enxYLZ6L5evTy-J-WVjNRMG18cZZx0ETJpURtZWcGwpcCqvqplaN0Uo2rCTcUc_NeN36xivhAbRVfIZu_7A2xZyT89U-tTtIx4qS6mSlGq1UJyv8FwXoWec
CitedBy_id crossref_primary_10_1097_YIC_0000000000000544
crossref_primary_10_1097_MD_0000000000025363
crossref_primary_10_1097_YIC_0000000000000498
crossref_primary_10_1007_s00702_016_1630_6
crossref_primary_10_3389_fpsyt_2020_576877
crossref_primary_10_1038_s41398_022_02112_8
crossref_primary_10_1016_j_euroneuro_2019_03_010
crossref_primary_10_1016_j_drugalcdep_2020_108225
crossref_primary_10_2196_24433
crossref_primary_10_1016_j_drugalcdep_2023_110925
crossref_primary_10_1177_0269881115570082
crossref_primary_10_1038_s44220_024_00261_x
crossref_primary_10_1097_JCP_0000000000001457
crossref_primary_10_1016_j_drugpo_2024_104457
crossref_primary_10_1089_can_2017_0018
crossref_primary_10_1111_add_14959
crossref_primary_10_1016_j_psychres_2014_10_010
crossref_primary_10_1089_brain_2014_0314
crossref_primary_10_3389_fnins_2023_1163600
Cites_doi 10.1111/j.1365‐2125.2011.03970.x
10.1097/JCP.0b013e318204825b
10.1017/S0033291712001924
10.1111/bcp.12071
10.1192/bjp.178.2.101
10.1016/S0163‐7258(02)00257‐7
10.2307/2346830
10.1111/bcp.12141
10.1111/j.1365‐2125.2008.03329.x
10.1016/S0140‐6736(05)66374‐X
10.1038/npp.2008.138
10.1038/sj.npp.1395214
10.1017/S1461145711000526
10.1201/9781420011234
10.1016/j.neuroimage.2012.07.051
10.2165/11585260-000000000-00000
10.1111/j.2044‐8341.1974.tb02285.x
10.1038/sj.npp.1300496
10.1177/0269881108089870
10.2165/11539000-000000000-00000
10.1002/ptr.3375
10.1192/bjp.bp.109.072249
10.1016/0028‐3908(71)90039‐6
10.1001/archgenpsychiatry.2010.152
10.1177/0269881112446534
10.1111/j.1365‐2125.2011.04164.x
10.1038/npp.2009.184
10.1136/bmj.38267.664086.63
10.1145/331499.331504
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1002/mpr.1424
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1557-0657
EndPage 256
ExternalDocumentID 10_1002_mpr_1424
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
24P
29J
31~
33P
36B
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAONW
AAYXX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIJN
ABIVO
ABLJU
ABUWG
ACBWZ
ACCFJ
ACGFS
ACHQT
ACMXC
ACPOU
ACSCC
ACXQS
ADBBV
ADEOM
ADIZJ
ADMGS
ADPDF
ADXAS
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFGKR
AFKRA
AFPWT
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZQEC
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CCPQU
CITATION
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DU5
DWQXO
EAD
EAP
EAS
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
EPS
ESX
F00
F01
F04
F5P
FEDTE
FUBAC
FYUFA
G-S
G.N
GNP
GNUQQ
GODZA
GROUPED_DOAJ
H.X
HF~
HVGLF
HZ~
IAO
IHR
ITC
IX1
J0M
JPC
LAW
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M2M
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
NF~
O66
O9-
OIG
OK1
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PIMPY
PQQKQ
PSYQQ
Q.N
Q11
QB0
QRW
R.K
ROL
RPM
RWI
RX1
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WQJ
WRC
WVDHM
WXI
XG1
XV2
ZZTAW
~IA
~WT
ID FETCH-LOGICAL-c724-378f8ece3a7025684bc53381a354c6bdb6d8765d2903e1f38822cfdf64faa7c63
ISSN 1049-8931
IngestDate Thu Sep 26 16:12:09 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c724-378f8ece3a7025684bc53381a354c6bdb6d8765d2903e1f38822cfdf64faa7c63
PageCount 12
ParticipantIDs crossref_primary_10_1002_mpr_1424
PublicationCentury 2000
PublicationDate 2014-06-00
PublicationDateYYYYMMDD 2014-06-01
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-06-00
PublicationDecade 2010
PublicationTitle International journal of methods in psychiatric research
PublicationYear 2014
References e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_18_1
e_1_2_7_17_1
Compton D.R. (e_1_2_7_9_1) 1996; 277
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
Jolliffe I.T. (e_1_2_7_19_1) 2002
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
References_xml – ident: e_1_2_7_28_1
  doi: 10.1111/j.1365‐2125.2011.03970.x
– ident: e_1_2_7_21_1
  doi: 10.1097/JCP.0b013e318204825b
– ident: e_1_2_7_3_1
  doi: 10.1017/S0033291712001924
– ident: e_1_2_7_25_1
  doi: 10.1111/bcp.12071
– ident: e_1_2_7_2_1
  doi: 10.1192/bjp.178.2.101
– ident: e_1_2_7_4_1
  doi: 10.1016/S0163‐7258(02)00257‐7
– volume-title: Principal Component Analysis
  year: 2002
  ident: e_1_2_7_19_1
  contributor:
    fullname: Jolliffe I.T.
– ident: e_1_2_7_14_1
  doi: 10.2307/2346830
– ident: e_1_2_7_26_1
  doi: 10.1111/bcp.12141
– ident: e_1_2_7_34_1
  doi: 10.1111/j.1365‐2125.2008.03329.x
– ident: e_1_2_7_30_1
  doi: 10.1016/S0140‐6736(05)66374‐X
– ident: e_1_2_7_7_1
  doi: 10.1038/npp.2008.138
– ident: e_1_2_7_8_1
  doi: 10.1038/sj.npp.1395214
– ident: e_1_2_7_15_1
  doi: 10.1017/S1461145711000526
– volume: 277
  start-page: 586
  issue: 2
  year: 1996
  ident: e_1_2_7_9_1
  article-title: In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9‐tetrahydrocannabinol‐induced responses and apparent agonist activity
  publication-title: Journal of Pharmacology and Experimental Therapeutics
  contributor:
    fullname: Compton D.R.
– ident: e_1_2_7_12_1
  doi: 10.1016/S0140‐6736(05)66374‐X
– ident: e_1_2_7_13_1
  doi: 10.1201/9781420011234
– ident: e_1_2_7_24_1
  doi: 10.1016/j.neuroimage.2012.07.051
– ident: e_1_2_7_20_1
  doi: 10.2165/11585260-000000000-00000
– ident: e_1_2_7_6_1
  doi: 10.1111/j.2044‐8341.1974.tb02285.x
– ident: e_1_2_7_10_1
  doi: 10.1038/sj.npp.1300496
– ident: e_1_2_7_35_1
  doi: 10.1177/0269881108089870
– ident: e_1_2_7_32_1
  doi: 10.2165/11539000-000000000-00000
– ident: e_1_2_7_11_1
  doi: 10.1002/ptr.3375
– ident: e_1_2_7_17_1
  doi: 10.1192/bjp.bp.109.072249
– ident: e_1_2_7_29_1
  doi: 10.1016/0028‐3908(71)90039‐6
– ident: e_1_2_7_27_1
  doi: 10.1017/S1461145711000526
– ident: e_1_2_7_31_1
  doi: 10.1001/archgenpsychiatry.2010.152
– ident: e_1_2_7_22_1
  doi: 10.1177/0269881112446534
– ident: e_1_2_7_23_1
  doi: 10.1111/j.1365‐2125.2011.04164.x
– ident: e_1_2_7_5_1
  doi: 10.1038/npp.2009.184
– ident: e_1_2_7_16_1
  doi: 10.1136/bmj.38267.664086.63
– ident: e_1_2_7_18_1
  doi: 10.1145/331499.331504
– ident: e_1_2_7_33_1
  doi: 10.1177/0269881108089870
SSID ssj0018226
Score 2.0584507
Snippet Abstract The subjective effects of cannabis and its main psychoactive component Δ 9 ‐tetrahydrocannabinol (THC) have played an important part in determining...
SourceID crossref
SourceType Aggregation Database
StartPage 245
Title Profiling the subjective effects of Δ 9 ‐tetrahydrocannabinol using visual analogue scales
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NattAEF7cGEIvoW1S2qQtW2hORqm9Wq2lY5zYhIBLCS7kUszualVsXCnEUiA55RF66IP0SfoQfZKMNLuSSHNIexFmbcl45_P87TczhHwIecgHJhCeHEKsysEge1KHwotl0BcsAZfELwuFp5_EyRd-eh6cdzq_WqylIlcH-ubBupL_kSqsgVzLKtl_kGz9UFiA1yBfuIKE4fooGX-uBm67gqd1oZaovtosjf2j8X7EexD7O1pDbnLQMNcxmC6ZphJC42zVK6qcwdViXVTNAzCl01uDBC3JcNlQ3psMYqvvBI6iRla6Y1BX7aFb6bJSsa_MIl1l2TdX316d1I9qnsdZlt0Y61Iv8mbqvQH9ldohImWOyGacq7oVs1jiG6cW6jaLMeAN28oqXohUPPCdcMlYZRyU1DxsYO20NVYnW1SyturFtpTWijNsV_6XgcCGs98vLg_KEr_GCLqD_3u2sWYsYndnNoc75-WdT0iXgWoDndo9HB2PJvXJFThcAjtg4O9xDY_77KP71pYL1PJlZs_Ilg1C6CEi6jnpmPQF2ZxamsU2-VoDiwKwaAMsaoFFs4T-_kkj-uf2x0NwohWcKMKJOjhRhNMOmU3Gs6MTz87h8PSQcTBBYRIabXz4O8O2hlxpiBHCgfQDroWKlYjBpAYxi_q-GSQ-xGxMJ3EieCLlUAv_JdlIs9S8IhQe4ceRDCLw23kcMhUYlWhech-k6Svzmrx3OzO_wG4r8_s7v_uIz-yRpw3I3pCN_LIwb8F5zNU7K6874LN1kQ
link.rule.ids 315,783,787,27936,27937
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Profiling+the+subjective+effects+of+%CE%94+9+%E2%80%90tetrahydrocannabinol+using+visual+analogue+scales&rft.jtitle=International+journal+of+methods+in+psychiatric+research&rft.au=Kleinloog%2C+Dani%C3%ABl&rft.au=Roozen%2C+Frits&rft.au=De+Winter%2C+Willem&rft.au=Freijer%2C+Jan&rft.date=2014-06-01&rft.issn=1049-8931&rft.eissn=1557-0657&rft.volume=23&rft.issue=2&rft.spage=245&rft.epage=256&rft_id=info:doi/10.1002%2Fmpr.1424&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_mpr_1424
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1049-8931&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1049-8931&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1049-8931&client=summon